Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer
Researchers have identified a promising new target in the treatment of pancreatic cancer. A new study in The American Journal of Pathology demonstrates that blocking complement factor B (CFB), a pivotal enzyme in the alternative complement pathway, halts cancer growth and alters the tumor microenvironment. The greatest tumor suppression was observed when CFB inhibition was combined with…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Discontinuing statins generally safe for older adults without heart disease
United Kingdom
-
Intravenous antiplatelet therapy may improve heart function in cardiogenic shock patients compared to oral medication
United Kingdom
-
Five AI models tackled 227 pharmacy exam questions. Here's where they struggled
United Kingdom
-
An inside look at a molecular switch that triggers inflammation
United Kingdom
-
Few meet major clinical response criteria after treatment escalation for lupus
United Kingdom
-
New blood test claims to detect 50+ cancers before symptoms—but there's no proof it reduces cancer death risk
United Kingdom
-
Researchers reveal how inhaled nanoplastics trigger lung inflammation
United Kingdom
-
Intensive blood pressure therapy did not cut cardiovascular events in adults with diabetes
United Kingdom